"Great to work with, is creative, is whip-smart, so you can trust that she will reach the right conclusions." - LMG Life Sciences
Cheryl Reicin's practice focuses on biotechnology, medical device, health information and other technology-based companies, and representation of private equity/venture capital funds and investment banks that fund such companies. She also represents academic medical centers and universities. Her practice centers on U.S., Canadian and Israeli entities.
Cheryl assists companies in formulating domestic and international growth strategies and in sourcing capital. She advises on venture and later-stage financings, IPOs, mergers and acquisitions, licensing transactions and joint ventures or alliances with strategic partners. She also coordinates domestic and international structuring, intellectual property planning and regulatory strategy.
Women's Executive Network (WXN) Canada's Most Powerful Women: Top 100 Award (2014, 2016, 2017)
Chambers & Partners’ Chambers Canada—Leading lawyer in Canada, life science (2017-2018)
LMG Life Sciences— Finance & Transactional Lawyer of the Year (2013); LMG Life Sciences Star (2014-2017)
Best Lawyers' Best Lawyers in Canada—2014 Biotechnology Law Lawyer of the Year; Leading lawyer in biotechnology law (2010-2018)
Law Business Research’s Who’s Who Legal Canada and New York—Leading lawyer in life sciences (2010-2018)
Intellectual Asset Management's IAM Patent 1000: The World's Leading IP Transactions —Leading lawyer globally (2012-2016)
Lexpert/Thomson Reuters Canada’s Canadian Legal Lexpert Directory—Repeatedly recommended practitioner in biotechnology and technology transactions (2008-2018)
Expert Guides' Women in Business Law Guide—Leading practitioner in life sciences (2014-2017)
Women of Influence, 2013 and 2014—Canada’s Top 25 Women of Influence (No. 1 in Professional Services category)
Law Business Research’s International Who’s Who of Life Sciences Lawyers—Leading U.S. lawyer in transactional law (2010-2014)
Law Business Research’s Who’s Who Legal: International Who’s Who of Business Lawyers—Leading lawyer in life sciences (2010-2014)
Intellectual Asset Management's IAM Licensing 250: The World's Leading Patent and Technology Licensing Lawyers 2010 and 2011/12—Leading lawyer globally
Practical Law Company’s Which Lawyer? Yearbook 2010-2012—Highly recommended lawyer in life sciences: corporate and commercial
Lexpert/American Lawyer Media’s Guide to the Leading 500 Lawyers in Canada 2006—Leading practitioner in serving the corporate midmarket
Before joining Torys, Cheryl was a partner of a large international law firm, where she chaired an 85-attorney life sciences group.